newsfilter
← Interviews
Lex Fridman1h 8m

Albert Bourla: Pfizer CEO | Lex Fridman Podcast #249

Albert Bourla, Lex Fridman

Interview

Host Alex Friedman engages Pfizer CEO Albert Bourla to dismantle pandemic-era polarization by detailing the company's $2.3 billion strategic gamble and the rigorous, transparent regulatory processes that secured global approval for its vaccines. Bourla clarifies the scientific realities behind the record-breaking development timelines, addresses controversies regarding data transparency and workforce mandates, and outlines Pfizer's capacity to rapidly adapt manufacturing for future variants or new antiviral therapies like Paxlovid. Through this dialogue, the discussion moves beyond conspiracy theories to focus on the intersection of high-stakes financial investment, strict safety protocols, and the human imperative to bridge trust gaps through empathetic science communication.